ReviewGene therapy2018
Interleukin-armed chimeric antigen receptor-modified T cells for cancer immunotherapy.
Y Huang et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
12 papers cite it
this papercites it
ReviewGene therapy2018
Y Huang et al.PubMed ↗Publisher ↗
No numbers read from the abstract.